RxDoctor Payments Data

Autumn Marcy, PA

Medical · Monaca, PANPI 1043793854

Payments from drug & device makers

$2,227in general payments, 2019–2025

Across 128 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$303
  • Amgen$196
  • Boehringer Ingelheim$178
  • Lilly USA, LLC$172
  • GSK$170
  • AbbVie$162
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$2,227100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,227 in reported general payments places this provider in the 80th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$33,481
Medicare patients
70
Services billed
392

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban114$46,369
RybelsusSemaglutide20$21,083
EntrestoSacubitril/Valsartan25$15,359
Budesonide90$12,479
XareltoRivaroxaban22$9,822
JanuviaSitagliptin Phosphate24$9,360
AbrysvoRsv Vacc, Pref A And Pref B/Pf29$9,066
FarxigaDapagliflozin Propanediol18$8,994
TresibaInsulin Degludec19$6,913
ArexvyRsvpref3 Antigen/As01e/Pf13$4,156
Sevelamer Carbonate11$3,727
Gabapentin106$3,458
Midodrine Hcl68$2,594
Divalproex Sodium55$2,407
Ipratropium-AlbuterolIpratropium/Albuterol Sulfate123$2,264

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$76$55,436143 claims
Novo NordiskRybelsus, Tresiba, Novolog$303$28,96051 claims
MerckJanuvia$74$9,36024 claims
AstraZenecaFarxiga$148$8,99418 claims
GSKArexvy$170$4,15613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Monaca

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →